Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY DRUG TYPE
? Nintedanib
? Pirfenidone
? Others
PART 6. MARKET BREAKDOWN BY ACTION MODE
? Antifibrotic agent
? Tyrosine kinase inhibitor
? Other
PART 7. MARKET BREAKDOWN BY END USER
? Hospital and clinic
? Others
PART 8. MARKET BREAKDOWN BY REGION
? North America
? Europe
? Asia-Pacific
? MEA (Middle East and Africa)
? Latin America
PART 9. KEY COMPANIES
? Boehringer Ingelheim International GmbH
? Bristol Myers Squibb Company
? Cipla Limited
? FibroGen Inc.
? Horizon Therapeutics Public Limited Company
? Jubilant Pharma Limited
? MediciNova Inc.
? Merck & Co. Inc.
? Roche Holding AG
? United Therapeutics Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER